Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberd Asia Inc Regulatory News (AAIF)

Share Price Information for Aberd Asia Inc (AAIF)

Share Price is delayed by 15 minutes
Get Live Data
326.00    -5.00 (-1.51%)
Bid:
323.00
Ask:
327.00
Spread: 4.00 (1.238%)
Market Cap: £464.60m
AAIF Live PriceLast checked at - London Stock Exchange

Intraday Aberd Asia Inc Share Chart

First Interim Dividend

15 Apr 2026 07:00

RNS Number : 4638A
Aberdeen Asian Income Fund Limited
15 April 2026
 

Aberdeen Asian Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300U76MLZF5F8MN87

 

15 April 2026

 

Declaration of First Interim Dividend

 

 

Highlights

 

· Annualised dividend yield of 6.8%.

· First quarterly interim dividend of 4.47p per share.

· Share price total return of 33.4% for the 12 month period ended 31 March 2026.

 

The Board is pleased to declare a first quarterly interim dividend of 4.47p per share for the year ended 31 December 2026. Based on a share price of 262p on 31 March 2026, this equates to an annualised dividend yield of 6.8%.

 

The first interim dividend will be paid on 22 May 2026 to shareholders on the register at the close of business on 24 April 2026. The ex-dividend date is 23 April 2026.

 

Shareholders who hold their shares on the main register are reminded that the Company's Registrar, Computershare Investor Services PLC, operates a dividend re-investment plan ("DRIP"). This can be a good way of building up a shareholding in the Company over time, whereby quarterly dividends are reinvested automatically in new shares. The deadline for elections under the DRIP is 30 April 2026.

 

Shareholders who hold their shares through a stockbroker or online dealing platform should be able to request for their dividends to be re-invested in a similar way, by contacting their stockbroker or selecting this option through their online dealing account.

 

 

Note:

The Company's dividend policy is to set the dividend at 1.5625% per quarter of the Company's net asset value ("NAV"), equating to approximately 6.25% of NAV per annum. The dividend is calculated using the Company's NAV on the last business day of the preceding financial quarter (i.e. the end of March, June, September and December). The first quarterly interim dividend of 4.47p per share is based on 1.5625% of the Company's NAV of 286.12p per share as at 31 March 2026.

 

 

For further information, please contact:

 

Aberdeen (Investment Manager):

Ben Heatley, Head of Closed End Fund Sales

Ben.Heatley@aberdeenplc.com

 

Maria Allen, Client Director, Closed End Funds

Maria.Allen@aberdeenplc.com

 

Peel Hunt LLP (Corporate Broker):

Luke Simpson, Huw Jeremy (Investment Banking)

Alex Howe, Richard Harris (Sales)

020 7418 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVIIMFTMTMBBIF
Date   Source Headline
27th Jan 20251:24 pmRNSGearing disclosure
27th Jan 202512:47 pmRNSNet Asset Value(s)
24th Jan 20255:20 pmRNSTransaction in Own Shares
24th Jan 202512:33 pmRNSNet Asset Value(s)
23rd Jan 20255:18 pmRNSTransaction in Own Shares
23rd Jan 202512:33 pmRNSNet Asset Value(s)
22nd Jan 20255:16 pmRNSTransaction in Own Shares
22nd Jan 202512:30 pmRNSNet Asset Value(s)
21st Jan 202512:34 pmRNSNet Asset Value(s)
20th Jan 202512:05 pmRNSGearing disclosure
20th Jan 202511:44 amRNSNet Asset Value(s)
17th Jan 20255:05 pmRNSTransaction in Own Shares
17th Jan 202511:52 amRNSNet Asset Value(s)
16th Jan 20255:13 pmRNSTransaction in Own Shares
16th Jan 20251:05 pmRNSNet Asset Value(s)
16th Jan 20257:00 amRNSDividend Policy, Declaration and Continuation Vote
15th Jan 20255:11 pmRNSTransaction in Own Shares
15th Jan 202511:51 amRNSNet Asset Value(s)
14th Jan 202512:17 pmRNSNet Asset Value(s)
13th Jan 20251:00 pmRNSGearing disclosure
13th Jan 202512:03 pmRNSNet Asset Value(s)
10th Jan 20255:04 pmRNSPortfolio disclosure
10th Jan 202511:22 amRNSNet Asset Value(s)
9th Jan 202512:19 pmRNSNet Asset Value(s)
8th Jan 20255:07 pmRNSTransaction in Own Shares
8th Jan 202512:42 pmRNSNet Asset Value(s)
7th Jan 20255:10 pmRNSTransaction in Own Shares
7th Jan 20252:58 pmRNSMonth End Net Asset Value(s)
7th Jan 202511:50 amRNSNet Asset Value(s)
6th Jan 20252:06 pmRNSGearing disclosure
6th Jan 202511:37 amRNSNet Asset Value(s)
3rd Jan 20253:58 pmRNSQuarterly disclosure
3rd Jan 202512:47 pmRNSNet Asset Value(s)
2nd Jan 202510:26 amRNSTotal Voting Rights
31st Dec 202412:48 pmRNSNet Asset Value(s)
30th Dec 20241:48 pmRNSGearing disclosure
30th Dec 20241:01 pmRNSNet Asset Value(s)
27th Dec 202412:32 pmRNSNet Asset Value(s)
24th Dec 202412:41 pmRNSNet Asset Value(s)
23rd Dec 20241:10 pmRNSGearing disclosure
23rd Dec 202412:49 pmRNSNet Asset Value(s)
20th Dec 20241:14 pmRNSNet Asset Value(s)
19th Dec 20245:09 pmRNSTransaction in Own Shares
19th Dec 202412:33 pmRNSNet Asset Value(s)
18th Dec 20245:22 pmRNSTransaction in Own Shares
18th Dec 202411:58 amRNSNet Asset Value(s)
17th Dec 20245:13 pmRNSTransaction in Own Shares
17th Dec 202411:55 amRNSNet Asset Value(s)
16th Dec 20245:13 pmRNSTransaction in Own Shares
16th Dec 20243:09 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.